MBRX - Moleculin Biotech gains after early data for lead cancer therapy
2023-11-13 15:28:21 ET
More on Moleculin Biotech
- Moleculin Biotech, Inc. (MBRX) Q3 2023 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Moleculin Biotech
- Historical earnings data for Moleculin Biotech
- Financial information for Moleculin Biotech
For further details see:
Moleculin Biotech gains after early data for lead cancer therapy